04/04/2025
7:39 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025
7:33 AM | Trinity Biotech (Filer)
| Form 424B3 | |
03/30/2025
11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
03/25/2025
5:29 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
03/21/2025
4:00 PM | Trinity Biotech (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
03/14/2025
3:30 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025
6:30 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025
7:30 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025
8:00 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2025
7:36 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2025
4:15 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for TRIB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. |
01/28/2025
10:33 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024
3:14 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024
3:05 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/26/2024
5:19 PM | New Main Equity Co., Ltd. (Filed by)
Trinity Biotech (Subject)
| Form SCHEDULE 13D | |
12/26/2024
6:12 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
8:55 PM | MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/18/2024
11:02 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024
3:42 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/05/2024
3:30 PM | Trinity Biotech (Filer)
| Form 424B3 | |
12/02/2024
11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
11/29/2024
3:45 PM | Trinity Biotech (Filer)
| Form F-3/A | |
11/15/2024
4:00 PM | Trinity Biotech (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
11/15/2024
12:22 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
4:26 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
| Form SC 13D/A | |
11/07/2024
11:33 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
12:23 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
12:24 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024
9:35 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024
10:22 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
2:07 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
5:01 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
7:11 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024
4:14 PM | Trinity Biotech (Filer)
| Form 424B5 | |
09/10/2024
9:35 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
12:26 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024
9:52 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
10:59 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024
5:01 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
11:33 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2024
3:40 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Virtually Limitless Energy? (Ad) A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts.
This obscure company could be at the center of the next trillion-dollar energy revolution. One company’s discovery could change power forever |
08/20/2024
12:52 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
4:26 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
4:27 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
4:03 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:53 PM | Trinity Biotech (Filer)
| Form 424B5 | |
07/11/2024
5:55 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2024
11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
06/28/2024
1:34 PM | Trinity Biotech (Filer)
| Form F-3/A | |
06/21/2024
3:15 PM | Trinity Biotech (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
05/28/2024
6:55 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
12:15 PM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
05/07/2024
3:25 PM | Trinity Biotech (Filer)
| Form 424B3 | |
04/30/2024
4:14 PM | Trinity Biotech (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
04/30/2024
2:48 PM | Trinity Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/30/2024
11:28 AM | Trinity Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
